Stockreport

Erasca Announces $45 Million Oversubscribed Private Placement Financing

Erasca, Inc.  (ERAS) 
PDF SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) (“Erasca”), a clinical-stage precision oncology company singularly focused on discovering, de [Read more]